Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: The role of CD4+ T cells and IFN-γ

Journal of Immunology

Volumn 176, Issue 5, 2006, Pages 3108-3114

  Day, Yuan Ji ^a,c   Huang, Liping ^a   Ye, Hong ^a   Li, Li ^a   Linden, Joel ^a,b   Okusa, Mark D ^a,b,d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [3 [6 AMINO 9 (5 ETHYLCARBAMOYL 3,4 DIHYDROXYTETRAHYDRO 2 FURYL) 9H PURIN 2 YL] 2 PROPYNYL]CYCLOHEXANECARBOXYLIC ACID METHYL ESTER; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; CREATININE; GAMMA INTERFERON; RAG1 PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; KIDNEY CELL; KIDNEY ISCHEMIA; KNOCKOUT MOUSE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; REPERFUSION INJURY;

EID: 33644556141     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.5.3108     Document Type: Article

References (42)

1. Olah, M. E., and G. L. Stiles. 1995. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 35: 581-606.
2. Linden, J. 2001. Molecular approach to adenosine receptors: receptor mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol. 41: 775-787.
3. 2A analogue reduces long-term neurologic injury after blunt spinal trauma. J. Surg. Res. 121: 130-134.
4. Day, Y.-J., L. Huang, H. Ye, J. Linden, and M. D. Okusa. 2005. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am. J. Physiol. 288: F722-F131.
5. Glover, D. K., L. M. Riou, M. Ruiz, G. W. Sullivan, J. Linden, J. M. Rieger, T. L. Macdonald, D, D. Watson, and G. A. Beller. 2004. Reduction of infarct size and post-ischemic inflammation from a highly selective adenosine A2A receptor agonist, ATL-146e, in reperfused canine myocardium. Am. J. Physiol. 288: H1851-H1858.
6. 2A adenosine receptor activation reduces ischemia-reperfusion injury in rat kidney. Am, J. Physiol. 277: F404-F412.
7. 2A adenosine receptors on bone marrow-derived cells. J. Clin. Invest. 112: 883-891.
8. Horie, Y., R. P. Chervenak, R. Wolf, M. E. Gerritsen, D. C. Anderson, S. Komatsu, and D. N. Granger. 1997. Lymphocytes mediate TNF-α-induced endothelial cell adhesion molecule expression: studies on SCID and RAG-1 mutant mice. J. Immunol 159: 5053-5062.
9. Kokura, S., R. E. Wolf, T. Yoshikawa, D. N. Granger, and T. Y. Aw. 2000. T-lymphocyte-derived tumor necrosis factor exacerbates anoxia-reoxygenation- induced neutrophil-endothelial cell adhesion. Circ. Res. 86: 205-213.
10. Le Moine, O., H. Louis, A. Demols, F. Desalle, F. Demoor, E. Quertinmont, M. Goldman, and J. Deviere. 2000. Cold liver ischemia-reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin 10 in mice. Hepatology 31: 1266-1274.
11. Nikbakht-Sangari, M., A. K. Qayumi, and P. A. Keown. 2000. The role of inflammatory mediators in the mechanism of the host immune response induced by ischemia-reperfusion injury. Immunol. Invest. 29: 13-26.
12. Varda-Bloom, N., J. Leor, D. G. Ohad, Y. Hasin, M. Amar, R. Fixler, A. Battler, M. Eldar, and D. Hasin. 2000. Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro. J. Mol. Cell. Cardiol. 32: 2141-2149.
13. + T-lymphocytes mediate ischemia/reperfusion- induced inflammatory responses in mouse liver. J. Clin. Invest. 100: 279-289.
14. + T cell as a major pathogenic factor in ischemic acute renal failure. J. Clin. Invest. 108: 1283-1290.
15. Rabb, H., F. Daniels, M. O'Donnell, M. Haq, S. R. Saba, W. Keane, and W. W. Tang. 2000. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury. Am. J. Physiol. 279: F525-F531.
16. Takada, M., A. Chandraker, K. C. Nadeau, M. H. Sayegh, and N. L. Tilney. 1997. The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J. Clin. Invest. 100: 1199-1203.
17. 2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19: 9192-9200.
18. Okusa, M. D., J. Linden, L. Huang, D. L. Rosin, D. F. Smith, and G. Sullivan. 2001. Enhanced protection from renal ischemia-reperfusion injury with A2A-adenosine receptor activation and PDE 4 inhibition. Kidney Int. 59: 2114-2125.
19. Kruisbeck, A. M. 1997. In vitro assays for mouse lymphocyte function. In Current Protocols in Immunology. Wiley Interscience, New York, pp. 3.0.1-3.1.5.
20. Linas, S. L., D. Whittenburg, P. E. Parsons, and J. E. Repine. 1992. Mild renal ischemia activates primed neutrophils to cause acute renal failure. Kidney Int. 42: 610-616.
21. Chiao, H., Y. Kohda, P. McLeroy, L. Craig, I. Housini, and R. A. Star. 1997. α-Melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J. Clin. Invest. 99: 1165-1172.
22. Willinger, C. C., H. Schramek, K. Pfaller, and W. Pfaller. 1992. Tissue distribution of neutrophils in postischemic acute renal failure. Virchows Arch. B Cell Pathol. Incl Mol. Pathol. 62: 237-243.
23. Day, Y. J., M. A. Marshall, L. Huang, M. J. McDuffie, M. D. Okusa, and J. Linden. 2004. Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am. J. Physiol. 286: G285-G293.
24. Bacon, K. B., B. A. Premack, P. Gardner, and T. J. Schall. 1995. Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269: 1727-1730.
25. Park, P., M. Haas, P. N. Cunningham, L. Bao, J. J. Alexander, and R. J. Quigg. 2002. Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes. Am. J. Physiol 282: F352-F357.
26. Burne-Taney, M. J., N. Yokota-Ikeda, and H. Rabb. 2005. Effects of combined T-and B-cell deficiency on murine ischemia reperfusion injury. Am. J. Transplant. 5: 1186-1193.
27. Burne-Taney, M. J., D. B. Ascon, F. Daniels, L. Racusen, W. Baldwin, and H. Rabb. 2003. B cell deficiency confers protection from renal ischemia reperfusion injury. J. Immunol 171: 3210-3215.
28. Yang, Z., Y. J. Day, M. C. Toufektsian, S. I. Ramos, M. Marshall, X. Q. Wang, B. A. French, and J. Linden. 2005. Infarct-sparing effect of A2A-adenosine receptor activation is due primarily to its action on lymphocytes. Circulation 111: 2190-2197.
29. Weiser, M. R., J. P. Williams, F. D. Moore, Jr., L. Kobzik, M. Ma, H. B. Hechtman, and M. C. Carroll. 1996. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J. Exp. Med. 183: 2343-2348.
30. Serrick, C., R. Adoumie, A. Giaid, and H. Shennib. 1994. The early release of interleukin-2, tumor necrosis factor-α and interferon-γ after ischemia reperfusion injury in the lung allograft. Transplantation 58: 1158-1162.
31. Horie, Y., R. Wolf, R. P. Chervenak, S. R. Jennihgs, and D. N. Granger. 1999. T-lymphocytes contribute to hepatic leukostasis and hypoxic stress induced by gut ischemia-reperfusion. Microcirculation 6: 267-280.
32. + T cells. J. Immunol. 174: 1073-1080.
33. Rabb, H. 2002. The T cell as a bridge between innate and adaptive immune systems: implications for the kidney. Kidney Int. 61: 1935-1946.
34. Bolli, R., B. S. Patel, M. O. Jeroudi, E. K. Lai, and P. B. McCay. 1988. Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap α-phenyl N-tert-butyl nitrone. J. Clin. Invest. 82: 476-485.
35. Baker, J. E., C. C. Felix, G. N. Olinger, and B. Kalyanaraman. 1988. Myocardial ischemia and reperfusion: direct evidence for free radical generation by electron spin resonance spectroscopy. Proc. Natl. Acad. Sci. USA 85: 2786-2789.
36. Reth, M. 2002. Hydrogen peroxide as second messenger in lymphocyte activation. Nat. Immunol. 3: 1129-1134.
37. Andersen, J. N., O. H. Mortensen, G. H. Peters, P. G. Drake, L. F. Iversen, O. H. Olsen, P. G. Jansen, H. S. Andersen, N. K. Tonks, and N. P. Møller. 2001. Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol. Cell. Biol. 21: 7117-7136.
38. Koshiba, M., D. L. Rosin, N. Hayashi, J. Linden, and M. V. Sitkovsky. 1999. Patterns of A2A-extracelluar adenosine receptor expression in different functional subsets of human peripheral T cells: flow cytometric studies with anti-A2A-receptor monoclonal antibodies. Mol. Pharmacol. 55: 614-624.
39. Huang, S., S. Apasov, M. Koshiba, and M. Sitkovsky. 1997. Role of A2a extra-cellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90: 1600-1610.
40. Koshiba, M., H. Kojima, S. Huang, S. Apasov, and M. V. Sitkovsky. 1997. Memory of extracellular adenosine A2A purinergic receptor-mediated signaling in murine T cells. J. Biol. Chem. 272: 25881-25889.
41. Sitkovsky, M. V., and A. Ohta. 2005. The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol. 26: 299-304.
42. s protein-coupled A2A adenosine receptor in vivo. J. Immunol. 173: 21-24.